Showing results (641-650 of 702) with videos related to

Sort By:
Pageof 71
Frontiers in Immunology|July 31, 2023
Gut lumen-leaked microbial DNA causes myocardial inflammation and impairs cardiac contractility in ageing mouse heartHong Gao, Ke Wang, Jorge A Suarez, et al.
BMC Medicine|February 8, 2026
Penpulimab in combination with lenalidomide and R-GemOx regimen (R2-GemOx-PD1i) in relapsed or refractory diffuse large B-cell lymphoma: a multicenter, single-arm, phase 2 trialJin-Hua Liang, Tong-Yao Xing, Wei-Ying Gu, et al.
Nature Metabolism|April 11, 2024
Adipose tissue macrophages secrete small extracellular vesicles that mediate rosiglitazone-induced insulin sensitizationTheresa V Rohm, Felipe Castellani Gomes Dos Reis, Roi Isaac, et al.
Cell Reports|November 17, 2023
MHC class II regulation of CD8+ T cell tolerance and implications in autoimmunity and cancer immunotherapyXiaojuan Zhou, Xian Jia, Zhe Huang, et al.
Acta Physiologica (Oxford, England)|March 30, 2021
Chromogranin A regulates gut permeability via the antagonistic actions of its proteolytic peptidesElke M Muntjewerff, Kechun Tang, Lisanne Lutter, et al.
Leukemia|January 8, 2025
EZH2 modulates mRNA splicing and exerts part of its oncogenic function through repression of splicing factors in CMLReinhard Brunmeir, Li Ying, Junli Yan, et al.
BMJ Open|May 13, 2026
Developing and validating an electronic health record-embedded AI model for managing multimorbid hospitalisation risk in patients with chronic RESpiratory disease (AiRES): a study protocolWei Ying Tan, Tae Yoon Lee, Kelvin Bryan Tan, et al.
Clinical and Translational Gastroenterology|March 20, 2026
Endoscopic application of tranexamic acid and sucralfate in upper gastrointestinal bleeding: A randomized controlled trialMeng-Hsuan Lu, Hsueh-Chien Chiang, Er-Hsiang Yang, et al.
The Journal of Biological Chemistry|May 1, 2013
The immunologically active oligosaccharides isolated from wheatgrass modulate monocytes via Toll-like receptor-2 signalingChia-Che Tsai, Chih-Ru Lin, Hsien-Yu Tsai, et al.
Blood Cancer Journal|June 17, 2025
A phase 2 study of Daratumumab with Thalidomide and dexamethasone in relapsed and/or Refractory Myeloma (RRMM)Chandramouli Nagarajan, Wei-Ying Jen, Melissa Ooi, et al.
Pageof 71